TL;DR — Kreider et al. 2003
Kreider and colleagues published one of the most comprehensive long-term safety studies on creatine supplementation, monitoring 98 serum health markers over 21 months in collegiate football players. The study found no clinically significant adverse changes in any health marker, including kidney function, liver function, blood lipids, electrolytes, and hematological parameters. This landmark safety data remains one of the strongest pieces of evidence for creatine’s long-term safety profile.
Background
Despite mounting evidence of creatine’s efficacy, concerns about long-term safety persisted in the early 2000s. Questions about kidney damage, liver stress, and metabolic disruption were common among the public and some healthcare professionals. Previous work by Poortmans and Francaux (2000) had shown no renal harm in up to 5 years of use (JR & M, 2000) , but comprehensive multi-marker monitoring over extended periods was lacking.
Kreider, a leading creatine researcher, designed this study to provide the most thorough safety assessment possible.
Study Design
- Participants: NCAA Division IA college football players
- Duration: 21 months (approximately 0 to 21 months of continuous monitoring)
- Supplementation: Creatine monohydrate at standard dosing
- Control: Athletes who chose not to use creatine
- Monitoring: 98 serum clinical chemistry markers measured at multiple time points
- Categories tested: Kidney function, liver function, blood lipids, electrolytes, complete blood count, metabolic markers, hormones
Key Findings
1. Kidney function remained normal
All renal function markers — blood urea nitrogen (BUN), serum creatinine, creatinine clearance, and estimated GFR — remained within normal clinical ranges throughout the 21-month period. No participant showed any sign of kidney stress or damage.
2. Liver function was unaffected
Hepatic markers including AST, ALT, GGT, and bilirubin showed no clinically significant changes. Creatine supplementation did not cause liver stress.
3. Cardiovascular markers stable
Blood lipid profiles (total cholesterol, LDL, HDL, triglycerides) were not adversely affected by creatine supplementation. Heart health markers remained normal.
4. No metabolic disruption
Electrolytes (sodium, potassium, chloride, calcium), blood glucose, insulin, and thyroid markers all remained within normal limits. Creatine did not cause metabolic imbalance.
5. Hematological parameters normal
Complete blood count, red blood cell indices, white blood cell differential, and platelet counts were all unaffected.
Significance
This study is significant because it:
- Represents one of the longest continuous monitoring periods for creatine safety
- Tested the broadest panel of health markers in any creatine safety study
- Used real-world athletes taking creatine as part of their normal training
- Found zero clinically significant adverse effects across 98 markers over 21 months
This data was later cited in the comprehensive 2017 ISSN position stand by Kreider et al. (RB et al., 2017) and complemented by Antonio et al. (2013) who found similar safety over up to 5 years (J & V, 2013) .
Practical Implications
- Long-term creatine use is safe: 21 months of supplementation produced no health concerns across 98 markers
- Kidney fears are unfounded: Direct measurement of renal function markers confirmed no kidney damage
- Liver is not affected: Hepatic function remained normal throughout
- No need for “cycling”: Continuous use does not cause progressive organ damage
- Annual health checkups remain sensible: While creatine is safe, regular health monitoring is good practice for anyone
Malaysian Relevance
Malaysian athletes and fitness enthusiasts who take creatine continuously can be reassured by this comprehensive safety data. The study’s findings apply regardless of ethnicity or geography — the biological safety profile of creatine monohydrate is consistent across populations. For Malaysians concerned about kidney health, this study directly addresses those fears with extensive data.
Limitations
- Observational design (not randomized) — athletes self-selected into creatine or control groups
- All participants were young, healthy, male college athletes
- Results may not directly generalize to elderly, clinical, or female populations
- Exact daily doses were not tightly controlled
Full Citation
Kreider RB, Melton C, Rasmussen CJ, et al. Long-term creatine supplementation does not significantly affect clinical markers of health in athletes. Molecular and Cellular Biochemistry. 2003;244(1-2):95-104. doi:10.1023/A:1022469320296
Sources & References
This article is based on the study by Kreider et al. published in Molecular and Cellular Biochemistry (2003) and contextualized with Poortmans et al. (2000), Antonio et al. (2013), and the 2017 ISSN position stand. All citations reference PubMed-indexed publications.